GB202108176D0 - Vector - Google Patents

Vector

Info

Publication number
GB202108176D0
GB202108176D0 GBGB2108176.5A GB202108176A GB202108176D0 GB 202108176 D0 GB202108176 D0 GB 202108176D0 GB 202108176 A GB202108176 A GB 202108176A GB 202108176 D0 GB202108176 D0 GB 202108176D0
Authority
GB
United Kingdom
Prior art keywords
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108176.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Touchlight IP Ltd
Original Assignee
Touchlight IP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Touchlight IP Ltd filed Critical Touchlight IP Ltd
Priority to GBGB2108176.5A priority Critical patent/GB202108176D0/en
Publication of GB202108176D0 publication Critical patent/GB202108176D0/en
Priority to KR1020237042463A priority patent/KR20240024807A/en
Priority to IL308705A priority patent/IL308705A/en
Priority to BR112023025408A priority patent/BR112023025408A2/en
Priority to PCT/GB2022/051437 priority patent/WO2022258967A1/en
Priority to AU2022289260A priority patent/AU2022289260A1/en
Priority to EP22730967.1A priority patent/EP4352238A1/en
Priority to CA3222751A priority patent/CA3222751A1/en
Ceased legal-status Critical Current

Links

GBGB2108176.5A 2021-06-08 2021-06-08 Vector Ceased GB202108176D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB2108176.5A GB202108176D0 (en) 2021-06-08 2021-06-08 Vector
KR1020237042463A KR20240024807A (en) 2021-06-08 2022-06-08 Lentivirus vectors
IL308705A IL308705A (en) 2021-06-08 2022-06-08 Lentiviral vector
BR112023025408A BR112023025408A2 (en) 2021-06-08 2022-06-08 CLOSED LINEAR DNA VECTOR SUITABLE FOR USE AS A LENTIVIRAL TRANSFER VECTOR, AND, METHOD FOR IMPROVING THE INFECTIOUS TITLE OF LENTIVIRAL PARTICLES WHEN THE TRANSFER VECTOR IS A CLOSED LINEAR DNA VECTOR
PCT/GB2022/051437 WO2022258967A1 (en) 2021-06-08 2022-06-08 Lentiviral vector
AU2022289260A AU2022289260A1 (en) 2021-06-08 2022-06-08 Lentiviral vector
EP22730967.1A EP4352238A1 (en) 2021-06-08 2022-06-08 Lentiviral vector
CA3222751A CA3222751A1 (en) 2021-06-08 2022-06-08 Lentiviral vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108176.5A GB202108176D0 (en) 2021-06-08 2021-06-08 Vector

Publications (1)

Publication Number Publication Date
GB202108176D0 true GB202108176D0 (en) 2021-07-21

Family

ID=76838732

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108176.5A Ceased GB202108176D0 (en) 2021-06-08 2021-06-08 Vector

Country Status (1)

Country Link
GB (1) GB202108176D0 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770140A1 (en) 1994-07-13 1997-05-02 Aventis Pharma S.A. Nucleic acid containing composition, preparation and uses of same
US5686279A (en) 1993-06-11 1997-11-11 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
WO2010086626A1 (en) 2009-01-30 2010-08-05 Touchlight Genetics Limited Production of closed linear dna
WO2012017210A1 (en) 2010-08-04 2012-02-09 Touchlight Genetics Limited Production of closed linear dna using a palindromic sequence
WO2016132129A1 (en) 2015-02-17 2016-08-25 Touchlight Genetics Limited Method of dna synthesis
WO2018033730A1 (en) 2016-08-16 2018-02-22 Touchlight IP Limited Closed linear dna production

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686279A (en) 1993-06-11 1997-11-11 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
EP0770140A1 (en) 1994-07-13 1997-05-02 Aventis Pharma S.A. Nucleic acid containing composition, preparation and uses of same
US6013240A (en) 1994-07-13 2000-01-11 Rhone-Poulenc Rorer Sa Nucleic acid containing composition, preparation and uses of same
WO2010086626A1 (en) 2009-01-30 2010-08-05 Touchlight Genetics Limited Production of closed linear dna
WO2012017210A1 (en) 2010-08-04 2012-02-09 Touchlight Genetics Limited Production of closed linear dna using a palindromic sequence
WO2016132129A1 (en) 2015-02-17 2016-08-25 Touchlight Genetics Limited Method of dna synthesis
WO2018033730A1 (en) 2016-08-16 2018-02-22 Touchlight IP Limited Closed linear dna production

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
"Culture of Animal Cells: A Manual of Basic Technique", 2000, WILEY-LISPS, article "Serum-Free Media", pages: 89 - 104,105-120
DULL ET AL.: "A third-generation lentivirus vector with a conditional packaging system", JOURNAL OF VIROLOGY, vol. 72, no. 11, 1998, pages 8463 - 8471, XP055715204, DOI: 10.1128/JVI.72.11.8463-8471.1998
FARSON ET AL.: "A new-generation stable inducible packaging cell line for lentiviral vectors", HUM GENE THER, vol. 12, no. 8, 2001, pages 981 - 97, XP002263325, DOI: 10.1089/104303401750195935
FELDMAN ET AL.: "The Nav channel bench series: plasmid preparation", METHODS X., vol. 1, 2014, pages 6 - 11
GODBEY W. T. ET AL., J. CONTROL RELEASE, vol. 60, 1999, pages 149160
GOLDING, M.MANN, M.: "A bidirectional promoter architecture enhances lentiviral transgenesis in embryonic and extraembryonic stem cells", GENE THERAPY, vol. 18, 2011, pages 817 - 826, XP055357962, Retrieved from the Internet <URL:https://doi.org/10.1038/gt.2011.23> DOI: 10.1038/gt.2011.26
MCMAHON ET AL., NIH PUBLIC ACCESS, vol. 27, 2015, pages 320 - 31
MERTEN ET AL.: "Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application.", HUMAN GENE THERAPY, vol. 22, no. 3, 2011, pages 343 - 356, XP055023182, Retrieved from the Internet <URL:http://doi.org/10.1089/hum.2010.060> DOI: 10.1089/hum.2010.060
MERTEN, O. W.HEBBEN, M.BOVOLENTA, C.: "Production of lentiviral vectors. Mol. Ther.", METHODS CLIN. DEV., vol. 3, 2016, pages 16017
MERTENHEBBENBOVOLENTA, MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, vol. 3, 2016, pages 16017
ORY ET AL.: "A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes", PNAS USA, vol. 93, 1996, pages 11400 - 11406, XP002030515, DOI: 10.1073/pnas.93.21.11400
SANBER ET AL.: "Construction of stable packaging cell lines for clinical lentiviral vector production", SCI REP, vol. 5, 2015, pages 9021, XP055491335, DOI: 10.1038/srep09021
SCHWEIZERMERTEN, CURRENT GENE THERAPY, vol. 10, no. 6, 2010, pages 474 - 486
SHAIMARDANOVA ET AL.: "Production and Application of Multicistronic Constructs for Various Human Disease Therapies", PHARMACEUTICS, vol. 11, no. 11, 2019, pages 580, XP055776188, DOI: 10.3390/pharmaceutics11110580
ZUFFEREY ET AL.: "Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo", NATURE BIOTECHNOLOGY, vol. 15, 1997, pages 871 - 875, XP002056816, DOI: 10.1038/nbt0997-871

Similar Documents

Publication Publication Date Title
CA204425S (en) Case
CA207972S (en) Case
GB201800903D0 (en) Vectors
GB202016862D0 (en) Vector
GB201715052D0 (en) Vectors
IL288419A (en) Recombinant herpesvirales vector
EP3938518A4 (en) Expression vector
GB201717524D0 (en) Vectors
GB201807945D0 (en) Vector production
GB202117741D0 (en) Feature vector feasibilty estimation
GB202014751D0 (en) Targeting vector
IL274178A (en) Vector add-with-carry instruction
GB202019108D0 (en) Vector
GB2597708B (en) Vector processing
CA203786S (en) Case
GB201913974D0 (en) Vector
EP4130019A4 (en) Metal-carbohydrate complex
IL274278A (en) Vectors
GB202108176D0 (en) Vector
GB202019286D0 (en) Expresison vector
GB202010009D0 (en) Vector
GB202009420D0 (en) Vector
GB202307366D0 (en) Vector
GB202212476D0 (en) Vector
GB202207077D0 (en) Vector

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)